NASDAQ:CABA

Cabaletta Bio Stock Predictions

etoro logo Buy CABA
*Your capital is at risk
$3.58
-0.100 (-2.72%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CABA Prediction Chart

CABA Predictions History

Latest community submissions for CABA.
Predictor Target Session Target Price Result Direction Accuracy Score
Jan 26, 2026 $3.09 -2.79% $2.95 V 95.21% 1
Jan 26, 2026 $3.12 -1.74% $2.95 V 94.08% 1
Jan 26, 2026 Bullish $2.95 X 0
Jul 1, 2025 $1.59 +4.73% $1.56 V 97.96% 1
Jul 1, 2025 $1.56 +2.95% $1.56 V 99.69% 5
Jul 1, 2025 Bearish $1.56 V 0
Jun 16, 2025 $2.08 +4.74% $1.94 X 92.29% 0
Jun 16, 2025 $2.05 +2.96% $1.94 X 94.11% 0
Jun 16, 2025 $2.15 +8.04% $1.94 X 88.89% 0
May 21, 2025 $1.81 -3.69% $1.80 V 99.13% 3
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CABA with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CABALETTA BIO, INC.
Cabaletta Bio
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce disease-causing autoantibodies or pathogenic B cells. The company's lead product candidate is DSG3-CAART,...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE